标题
OP449 inhibits breast cancer growth without adverse metabolic effects
作者
关键词
-
出版物
ENDOCRINE-RELATED CANCER
Volume 24, Issue 10, Pages 519-529
出版商
Bioscientifica
发表日期
2017-08-23
DOI
10.1530/erc-17-0077
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Adipocyte STAT5 deficiency promotes adiposity and impairs lipid mobilisation in mice
- (2016) Doris Kaltenecker et al. DIABETOLOGIA
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS
- (2016) Yehuda Handelsman et al. Endocrine Practice
- EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice
- (2016) Zara Zelenko et al. ENDOCRINE-RELATED CANCER
- Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy
- (2016) Gadi Shlomai et al. JOURNAL OF CLINICAL ONCOLOGY
- Excess Mortality among Persons with Type 2 Diabetes
- (2015) Mauro Tancredi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality
- (2015) Emily Jane Gallagher et al. PHYSIOLOGICAL REVIEWS
- Hepatic Oxidative Stress Promotes Insulin-STAT-5 Signaling and Obesity by Inactivating Protein Tyrosine Phosphatase N2
- (2014) Esteban N. Gurzov et al. Cell Metabolism
- Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia
- (2014) A. Agarwal et al. CLINICAL CANCER RESEARCH
- PP2A Inhibition Is a Common Event in Colorectal Cancer and Its Restoration Using FTY720 Shows Promising Therapeutic Potential
- (2014) I. Cristobal et al. MOLECULAR CANCER THERAPEUTICS
- Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer
- (2014) M. Janghorban et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deregulation of the phosphatase, PP2A is a common event in breast cancer, predicting sensitivity to FTY720
- (2014) Shawn Baldacchino et al. EPMA Journal
- Impaired expression of protein phosphatase 2A subunits enhances metastatic potential of human prostate cancer cells through activation of AKT pathway
- (2013) P Pandey et al. BRITISH JOURNAL OF CANCER
- Plasma C-Peptide, Mammographic Breast Density, and Risk of Invasive Breast Cancer
- (2013) T. P. Ahern et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Effect of Elevated Basal Insulin on Cancer Incidence and Mortality in Cancer Incident Patients: The Israel GOH 29-year follow-up study
- (2012) R. Dankner et al. DIABETES CARE
- Diabetes and Cause-Specific Mortality in a Prospective Cohort of One Million U.S. Adults
- (2012) P. T. Campbell et al. DIABETES CARE
- SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target
- (2011) D. J. Christensen et al. BLOOD
- Insulin- and Obesity-Related Variables in Early-Stage Breast Cancer: Correlations and Time Course of Prognostic Associations
- (2011) Pamela J. Goodwin et al. JOURNAL OF CLINICAL ONCOLOGY
- Apolipoprotein E and Peptide Mimetics Modulate Inflammation by Binding the SET Protein and Activating Protein Phosphatase 2A
- (2011) D. J. Christensen et al. JOURNAL OF IMMUNOLOGY
- Modulation of Protein Phosphatase 2A Activity Alters Androgen-Independent Growth of Prostate Cancer Cells: Therapeutic Implications
- (2011) A. Bhardwaj et al. MOLECULAR CANCER THERAPEUTICS
- Targeting SET/I2PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy
- (2011) C H Switzer et al. ONCOGENE
- Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia
- (2011) E J Gallagher et al. ONCOGENE
- Insulin-Mediated Acceleration of Breast Cancer Development and Progression in a Nonobese Model of Type 2 Diabetes
- (2010) R. Novosyadlyy et al. CANCER RESEARCH
- Identification of PP2A Complexes and Pathways Involved in Cell Transformation
- (2010) A. A. Sablina et al. CANCER RESEARCH
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes
- (2010) Yvonne Fierz et al. ENDOCRINE-RELATED CANCER
- Fasting C-Peptide Levels and Death Resulting From All Causes and Breast Cancer: The Health, Eating, Activity, and Lifestyle Study
- (2010) Melinda L. Irwin et al. JOURNAL OF CLINICAL ONCOLOGY
- Protein phosphatase 2A regulatory subunits and cancer
- (2008) Pieter J.A. Eichhorn et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome
- (2008) Pamela J. Goodwin et al. BREAST CANCER RESEARCH AND TREATMENT
- Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias
- (2008) Danilo Perrotti et al. CANCER AND METASTASIS REVIEWS
- The Apolipoprotein E-mimetic Peptide COG112 Inhibits the Inflammatory Response toCitrobacter rodentiumin Colonic Epithelial Cells by Preventing NF-κB Activation
- (2008) Kshipra Singh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Role of Endocrine Insulin-Like Growth Factor-I and Insulin in Breast Cancer
- (2008) Danielle Lann et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Multiple pathways regulated by the tumor suppressor PP2A in transformation
- (2008) Jukka Westermarck et al. TRENDS IN MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started